Dr. Syed Mustafa Shahkhan, MD

Dr. Shahkhan practices at Noran Neurological Clinic P.A. in Minneapolis, Minnesota.

Dr. Shahkhan's NPI, 1144422544, was assigned on June 5, 2007. Dr. Shahkhan holds Minnesota license 50338.

Dr. Shahkhan's primary practice is Noran Neurological Clinic P.A., at 3601 Minnesota Dr, Minneapolis, MN 55435 in Hennepin County. The practice phone is (612) 879-1000.

Dr. Shahkhan's primary practice is Noran Neurological Clinic P.A. in Minneapolis, Minnesota. Dr. Shahkhan is also affiliated with Abbott Northwestern Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Shahkhan to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shahkhan practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shahkhan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Shahkhan is licensed in Minnesota.

CMS data shows 14,297 Medicare services from Dr. Shahkhan across 21 procedure codes in 2024, for 489 Medicare patients. Medicare paid $149,045 for them. Every service was in an office.

CMS counts 489 Medicare patients who saw Dr. Shahkhan in 2024. The largest group is 65 to 74, with 184 patients. 59% of them have high blood pressure, and 55% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shahkhan's median patient age at 60, with 64% women.

In 2024, Dr. Shahkhan wrote 2,286 Medicare Part D claims for 457 patients. 89% of them were for generic drugs. CMS names the drug for 2,044 of them, across 50 drugs with 11 or more claims each, at $352,658 in total drug cost. In 2023, CMS named 1,906 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Shahkhan for performance year 2024, reported as part of a group. Dr. Shahkhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 40 general payments to Dr. Shahkhan from 3 drug and device companies from 2016 to 2018. Speaker and faculty fees make up the largest share, 93% of the total. Sanofi and Genzyme US Companies paid the most, $20,693.